DAFNA Capital Management LLC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
DAFNA Capital Management LLC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q1 2022$2,173,000
+3.6%
160,9830.0%0.57%
+7.2%
Q4 2021$2,098,000
+38.9%
160,9830.0%0.53%
+31.7%
Q3 2021$1,510,000
-8.4%
160,9830.0%0.40%
+16.2%
Q2 2021$1,648,000
-2.1%
160,983
+75.9%
0.34%
-13.8%
Q1 2021$1,684,000
+197.5%
91,531
+453.7%
0.40%
+138.1%
Q4 2020$566,00016,5310.17%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders